David Grayzel


David Grayzel is a partner at Atlas Venture. Since joining Atlas in 2010, David has co-founded and served as chief executive officer of numerous companies, including Arteaus Therapeutics, acquired by Eli Lilly in 2014, Annovation Biopharma acquired by The Medicines Company in 2015, and was a founding board member of Delinia acquired by Celgene i...

Roles at Q32 Bio

  • Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.